Literature DB >> 7728977

Chemoprevention by amiloride of experimental carcinogenesis in rat colon induced by azoxymethane.

M Tatsuta1, H Iishi, M Baba, H Uehara, A Nakaizumi.   

Abstract

The effects of amiloride on the incidence and histology of colon tumors induced by azoxymethane, on the labeling index of the colon mucosa and on the activity of ornithine decarboxylase in the colon wall were investigated in Wistar rats. Rats received 10 weekly injections of 7.4 mg/kg body wt azoxymethane and s.c. injections of 5 or 7.5 mg/kg body wt amiloride in depot form every other day for 35 weeks. Prolonged administration of amiloride at a dose of 7.5 mg/kg, but not 5 mg/kg, significantly reduced the incidence of colon tumors at week 35. However, administration of amiloride had little or no significant influence on the histological types of colon tumors and cancers. Administration of amiloride at 7.5 mg/kg significantly decreased the labeling index of the colon mucosa and ornithine decarboxylase activity in the colon wall during and after administration of azoxymethane. These findings suggest that amiloride inhibits development of colon tumors. A possible mechanism of inhibition of colon carcinogenesis by amiloride is its suppression of proliferation of colon tumor cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7728977     DOI: 10.1093/carcin/16.4.941

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  4 in total

Review 1.  Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency.

Authors:  Denis E Corpet; Sylviane Taché
Journal:  Nutr Cancer       Date:  2002       Impact factor: 2.900

2.  Amiloride sensitizes human pancreatic cancer cells to erlotinib in vitro through inhibition of the PI3K/AKT signaling pathway.

Authors:  Yuan-ting Zheng; Hui-ying Yang; Tao Li; Bei Zhao; Teng-fei Shao; Xiao-qiang Xiang; Wei-min Cai
Journal:  Acta Pharmacol Sin       Date:  2015-04-13       Impact factor: 6.150

3.  Control of pulmonary metastases of rat mammary cancer by inhibition of uPA and COX-2, singly and in combination.

Authors:  Douglas M Evans; Kimberly D Sloan Stakleff
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

4.  TAZ expression as a prognostic indicator in colorectal cancer.

Authors:  Hiu-Fung Yuen; Cian M McCrudden; Yu-Han Huang; Jill M Tham; Xiaoqian Zhang; Qi Zeng; Shu-Dong Zhang; WanJin Hong
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.